Animal Generic Drug Market Key Players, Trends, Growth Opportunities and Industry Forecast till 2028
“The growing competition in the pet medicine industry is fueling the penetration of animal generic drugs. However, generic drugs have been attributed to have lower profit margins for manufacturers and is therefore, hindering the market growth”
The global animal generic drug market has been estimated to foresee an explosive growth by the year 2028. “Veterinary product manufacturers have altered their prescribing methodologies by in-house pharmacy and availability of generic animal drugs so as to foster cost-effective treatments.” The growing competition in the pet medicine industry is fueling the penetration of animal generic drugs. However, generic drugs have been attributed to have lower profit margins for manufacturers and is therefore, hindering the market growth. Several national distributors have started to produce generic drugs under private label, which is propelling market expansion. Based on type, animal generic drug market has been segmented into Pharmaceuticals, Medicinal Feed Additives, and Biologicals. Broilers, Cows, Pigs, and others have been identified as application types of the global market. Geographical segmentation has presented a detailed analysis of animal generic drug market growth prospects across the regions of North America, the Asia Pacific, Europe, the Middle East, and Africa, and Latin America. The North American market dominates the brand-name versions attributed to incorporation of latest technological advancements and new delivery methods. The competitive landscape showcases the profiles and business strategies of the major players, along with their recent developments. Some of the dominant players operating in this market include Bayer Animal Health, Merck, Bimeda, Ceva Sante Animale, Boehringer Ingelheim, Huvepharma, Elanco, Norbrook, Vetoquinol, Perrigo, Merial and Zoetis among others. Get Sample Copy of this Report @